Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study

Figure 1

Elevated plasma IL-37 in chronic heart failure. (a) Plasma IL-37 in chronic heart failure (CHF) patients compared with control subjects (control); (b) plasma IL-37 levels in ischemic heart disease (IHD) subgroup and non-IHD subgroup; (c) plasma IL-37 levels in hypertension (HP) subgroup and nonhypertension subgroup (non-HP); (d) plasma IL-37 levels in diabetes mellitus (DM) subgroup and non-DM subgroup (non-DM).

(a)

(b)

(c)

(d)